18 December 2020 Biologics Spondyloarthritis Gilead will not pursue FDA approval of filgonitib for RA
15 December 2020 Analgesics Conditions Spondyloarthritis Vagus nerve stimulation for RA symptom control
15 December 2020 Cognitive Therapies Osteoarthritis Spondyloarthritis News bites: New treatment for scleroderma?
3 December 2020 Analgesics Conditions Spondyloarthritis Battle of the monotherapies: etanercept vs methotrexate
12 November 2020 Ankylosing Spondylitis Communicable Diseases Corticosteroids Gout NDIA Scleroderma Spondyloarthritis Some RA patients stuck in a drug switch cycle
7 October 2020 Ankylosing Spondylitis Conditions Spondyloarthritis More infections in RA patients on baricitinib
2 October 2020 Analgesics Axial spondyloarthritis Biologics Conditions Gout Spondyloarthritis Europe approves filgotinib despite FDA qualms
27 August 2020 Analgesics Axial spondyloarthritis Conditions Spondyloarthritis Filgotinib on hold: FDA delays decision to approve JAKi for RA
15 July 2020 Analgesics Conditions COVID-19 Medications Spondyloarthritis Sulfasalazine & hydroxychloroquine shortages easing
1 July 2020 Conditions Reactive Arthritis Spondyloarthritis Keep on screening for cervical dysplasia in women with lupus
11 June 2020 Analgesics Conditions Spondyloarthritis Tale of two studies: Thrombosis associated with JAK and TNF inhibitors for RA
5 June 2020 Analgesics Conditions Spondyloarthritis Opioid use for rheuma pain rising, warn European experts
